- Breath testing for liver diseases provides a safe, non-invasive method of assessing liver function by continuously measuring the by-product of 13C- methacetin metabolism in the breath of test subjects.
- The test also provides relatively accurate measure of fibrosis and inflammation levels.
- Breath testing avoids traumatic liver biopsy and extensive blood tests.
- In 2013, 29 million in EU and over 30 million in the USA have liver disease (1 in 10 Americans).
“The new test could be used to assess prognosis from the earliest stages of liver disease to cirrhosis, to help doctors determine whether a cirrhotic patient has enough liver function to undergo a surgical procedure, to prioritize patients for liver transplantation, and perhaps to decide when patients need to start therapy for chronic viral hepatitis…”Gadi Lalazar, M.D., Hebrew University- Hadassah Medical Center, Jerusalem